Adverse drug reactions (ADRs) in patients with HIV infection. A prospective study

International Journal of Clinical Pharmacology and Therapeutics

Volumn 37, Issue 1, 1999, Pages 34-40

  Gonzalez Martin G ^a   Yanez C G ^a   Gonzalez Contreras L ^a   Labarca, J ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Adverse drug reactions; AZT; Cotrimoxazol; HIV positive patients

Indexed keywords

AMITRIPTYLINE; AZITHROMYCIN; CD4 ANTIGEN; CLAVULANIC ACID; CLOXACILLIN; COTRIMOXAZOLE; DAPSONE; FLUCONAZOLE; ISONIAZID; RIFAMPICIN; ZIDOVUDINE;

ABDOMINAL PAIN; ADULT; ANEMIA; ARTICLE; BIOCHEMISTRY; BLOOD DISEASE; BLOOD EXAMINATION; CHILE; CLINICAL ARTICLE; DIARRHEA; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; FEMALE; FEVER; GRANULOCYTOPENIA; HEART PALPITATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FUNCTION; LABORATORY TEST; LIVER DISEASE; LIVER FUNCTION; LYMPHOCYTE COUNT; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PHOTOSENSITIVITY DISORDER; PROSPECTIVE STUDY; SYMPTOM; URTICARIA;

ANTI-INFECTIVE AGENTS; FEMALE; HEPATITIS, TOXIC; HIV INFECTIONS; HUMANS; MALE; PROSPECTIVE STUDIES; SKIN DISEASES;

EID: 0345004139     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Benichou C, Eliaszewicz M, Flahault A 1994 Adverse drug reactions in HIV-seropositive patients. Pharmacol Drug Saf 3: 31-40
2. Burger DM, Meenhorst PL, ten Napel CH, Mulder JW, Neef C, Koks CH, Bult A, Beijnen JH 1994 Pharmacokinetics variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interaction. AIDS 8: 1683-1689
3. Cabo HA, Castro Rios M, de Montes de Oca NF 1986 Infectious mononucleosis and ampicillin. Med Cutan Ibero Lat Am 14: 177-180
4. Carr A, Swanson C. Penny R, Cooper DA 1993 Clinical and laboratory markers of hypersensibility to trimethroprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J Infect Dis 167: 180-185
5. Centers for Disease Control 1987 Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 36 (Suppl): 1-15
6. Coopman SA, Stern RS 1991 Cutaneous drug reactions in human immnudeficiency virus infection. Arch Dermatol 127: 714-717
7. Corcuera T, Alonso MJ, Picazo A, Gómez F, Roldán M, Abad M et al 1996 Hepatic morphological alterations induced by zidovudine in an experimental model. Pathol Res Pract 192: 182-187
8. Chin TW, Vandenbroucke A, Fong IW 1995 Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients. Antimicrob Agents Chemother 39: 28-33
9. Devoto FM, González C, Iannantuono R, Serra HA, González CD, Sáenz C 1997 Risk factors for hepatotoxicity induced by antiturbeculosis drugs. Acta Physiol Pharmacol Ther Latinoam 47: 197-202
10. González-Martin G, Díaz-Molina MS, Martinez AM, Ortiz M 1991 Heparin-induced hyperkalemia: a prospective study. Int J Clin Pharmacol Ther Toxicol 29: 446-450
11. Gordin FM, Simon GL, Wofsy CB, Mills J 1984 Adverse drug reactions to trimethoprim-sulfamethoxazole in patients with the acquired immnuno deficiency syndrome. Ann Int Med 100: 495-499
12. Guarner J, del Río C, Carr D, Hendrix LE, Eley JW, Unger ER 1991 Non-Hodkin's lymphomas in patients with human immunodeficiency virus infection. Presence of Epstein-Barr virus by in situ hybridization, clinical presentations, and follow-up. Cancer 68: 2460-2465
13. Haverkos HW 1990. Nitrtite-inhalant abuse and AIDS-related Kaposi's sarcome. J Acquir Immune Defic Syndr 3 (Suppl 1): S47-50
14. Iribarren JA, Arrizabalaga J, Garde C, Barcia MJ, Rodriguez-Arrondo F, Zulaica D 1989 Adverse drug reactions in AIDs patients. Int Conf AIDS 497: Abstr b 601
15. Kaplan LD, Wofsy CB, Volberding PA 1987 Treatment of patients with acquired immunodeficiency syndrome and associated manifestation. JAMA 257: 1367
16. Levy M 1997 Role of viral infections in the induction of adverse drug reactions. Drug Saf 16: 1-8
17. McLachlan AJ, Tett SE 1996 Pharmacokinetics of fluconazole in people with HIV infection: a population analysis. Br J Clin Pharmacol 41: 291-298
18. Moore RD, Fortgang I, Keruly J, Chaisson RE 1996 Adverse events from drug therapy for human immunodeficiency virus disease. Am J Med 101: 34-40
19. Naranjo CA, Busto U, Sellers EM 1981 A method for estimating the probability od adverse drug reactions. Clin Pharmacol Ther 20: 239-245
20. Naranjo CA, Busto U 1989 Adverse drug reactions. In: Kalant H. Roschlau WHE (eds) Principles of Medical Pharmacology 2th Ed. Decker, Toronto, pp 658-665
21. Roudier C, Caumes E, Rogeaux O, Bricaire F, Gentilini M 1994 Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome and Pneumocystiis carinii pneumonia. Arch Dermatol 130: 1383-1386
22. Van der Ven AJ, Koopmans PP, Vree TB, van der Meer JW 1994 Drug intolerance in HIV disease. J Antimicrob Chemother 34: 1-5
23. Veenstra J, Veugelers PJ, Keet IP, van der Ven AJ, Miedema F, Lange JM, Coutinho RA 1997 Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse drug reactions to trimethoprim-sulfamethoxazole prophylaxis. Clin Infect Dis 24: 936-941
24. World Health Organization 1966 Technique Report Services 341: 7